Your browser doesn't support javascript.
loading
Compatibility of Lactated Ringer's Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Vallée, Margaux; Barthélémy, Isabelle; Friciu, Mihaela; Pelletier, Élaine; Forest, Jean-Marc; Benoit, France; Leclair, Grégoire.
Afiliação
  • Vallée M; Pharmacist, Hôpitaux universitaires de Genève, Switzerland.
  • Barthélémy I; Daniel Vermette Pharmacy, Montréal, QC, Canada.
  • Friciu M; Faculté de pharmacie, Université de Montréal, QC, Canada.
  • Pelletier É; CHU Sainte-Justine, Montréal, QC, Canada.
  • Forest JM; CHU Sainte-Justine, Montréal, QC, Canada.
  • Benoit F; CHSLD Vigi Yves-Blais, Mascouche, QC, Canada.
  • Leclair G; Faculté de pharmacie, Université de Montréal, QC, Canada.
Hosp Pharm ; 56(4): 228-234, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34381254
ABSTRACT

Objective:

To test the compatibility of intravenous (IV) lactated Ringer's injection (LR) with 94 injectable (IV) drugs during simulated Y-site administration.

Methods:

Ninety-four IV drugs were investigated for compatibility with LR (Baxter). Each sample was prepared in duplicate and performed at room temperature. Two observers performed visual evaluation independently immediately upon mixing and then 15 minutes, 1 hour, 2 hours, 3 hours, and 4 hours after admixture. Another observer performed a particle counting test on 1 of the 2 duplicates of each admixture that did not immediately show incompatibility and then after 4 hours by a light obscuration particle count test.

Results:

Of the 94 tested drugs, 86 were found to be compatible with LR. A total of 8 drugs were found to be physically incompatible. Of these incompatible drugs, 7 were directly identified visually and 1 was confirmed by the light obscuration particle count test.

Conclusion:

Lactated Ringer's injection was physically compatible for 4 hours with 86 tested drugs during simulated Y-site administration. Eight drugs, ciprofloxacin, cyclosporine, diazepam, ketamine, lorazepam, nitroglycerin, phenytoin, and propofol, were found to be incompatible and should not be administered with LR.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hosp Pharm Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hosp Pharm Ano de publicação: 2021 Tipo de documento: Article